As Of | Filing | | Doc. | | Page | | Title | Docs. |
---|
| | | |
5/16/23 | | 424B3 | | | | 1 | | About This Prospectus | 2 |
| | | | | | 1 | | Business | 3 |
| | | | | | 1 | | Cautionary Statement Concerning Forward-Looking Statements | 2 |
| | | | | | 1 | | Certain Relationships and Related Party Transactions | 2 |
4/17/23 | | 10-K | | | | 1 | | Certain Relationships and Related Transactions, and Director Independence | 1 |
| | | | | | 1 | | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure | 1 |
8/15/23 | | 10-Q | | | | 1 | | Condensed Consolidated Balance Sheets as of June 30, 2023 (unaudited) and December 31, 2022 | 1 |
5/15/23 | | 10-Q | | | | 1 | | Condensed Consolidated Balance Sheets as of March 31, 2023 (unaudited) and December 31, 2022 | 1 |
11/14/23 | | 10-Q | | | | 1 | | Condensed Consolidated Balance Sheets as of September 30, 2023 (unaudited) and December 31, 2022 | 1 |
| | | | | | 1 | | Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022 (unaudited) | 1 |
8/15/23 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2023 and 2022 (unaudited) | 1 |
5/15/23 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022 (unaudited) | 1 |
11/14/23 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Changes in Stockholders' Deficit for each of the quarters in the nine-month periods ended September 30, 2023 and 2022 (unaudited) | 1 |
8/15/23 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Changes in Stockholders' Deficit for each of the quarters in the six-month periods ended June 30, 2023 and 2022 (unaudited) | 1 |
5/15/23 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Changes in Stockholders' Deficit for the three months ended March 31, 2023 and 2022 (unaudited) | 1 |
11/14/23 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2023 and 2022 (unaudited) | 1 |
8/15/23 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2023 and 2022 (unaudited) | 1 |
5/15/23 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Operations for the three months ended March 31, 2023 and 2022 (unaudited) | 1 |
4/17/23 | | 10-K | | | | 1 | | Consolidated Balance Sheets as of December 31, 2022 and 2021 | 1 |
| | | | | | 1 | | Consolidated Statements of Cash Flows for the Years Ended December 31, 2022 and 2021 | 1 |
| | | | | | 1 | | Consolidated Statements of Operations for the Years Ended December 31, 2022 and 2021 | 1 |
| | | | | | 1 | | Consolidated Statements of Stockholders' Deficit for the Years Ended December 31, 2022 and 2021 | 1 |
11/14/23 | | 10-Q | | | | 1 | | Controls and Procedures | 4 |
| | | | | | 1 | | Defaults Upon Senior Securities | 3 |
5/16/23 | | 424B3 | | | | 1 | | Description of Capital Stock | 2 |
| | | | | | 1 | | Description of the Securities We Are Offering | 2 |
4/17/23 | | 10-K | | | | 1 | | Directors, Executive Officers and Corporate Governance | 1 |
| | | | | | 1 | | Disclosure Regarding Foreign Jurisdictions that Prevent Inspections | 1 |
5/16/23 | | 424B3 | | | | 1 | | Executive Compensation | 3 |
11/14/23 | | 10-Q | | | | 1 | | Exhibits | 3 |
4/17/23 | | 10-K | | | | 1 | | Exhibits and Financial Statement Schedules | 1 |
5/16/23 | | 424B3 | | | | 1 | | Experts | 2 |
11/14/23 | | 10-Q | | | | 1 | | Financial Information | 3 |
| | | | | | 1 | | Financial Statements | 3 |
4/17/23 | | 10-K | | | | 1 | | Financial Statements and Supplementary Data | 1 |
| | | | | | 1 | | Form 10-K Summary | 1 |
5/16/23 | | 424B3 | | | | 1 | | Incorporation of Certain Information by Reference | 2 |
| | | | | | 1 | | Legal Matters | 2 |
11/14/23 | | 10-Q | | | | 1 | | Legal Proceedings | 4 |
5/16/23 | | 424B3 | | | | 1 | | Management | 2 |
11/14/23 | | 10-Q | | | | 1 | | Management's Discussion and Analysis of Financial Condition and Results of Operations | 6 |
4/17/23 | | 10-K | | | | 1 | | Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities | 1 |
5/16/23 | | 424B3 | | | | 1 | | Market Price for Common Equity and Related Stockholder Matters | 2 |
11/14/23 | | 10-Q | | | | 1 | | Mine Safety Disclosures | 4 |
| | | | | | 1 | | Notes to Condensed Consolidated Financial Statements (unaudited) | 3 |
4/17/23 | | 10-K | | | | 1 | | Notes to Consolidated Financial Statements | 1 |
11/14/23 | | 10-Q | | | | 1 | | Other Information | 4 |
4/17/23 | | 10-K | | | | 1 | | Part I | 1 |
11/14/23 | | 10-Q | | | | 1 | | Part I -- Financial Information | 3 |
4/17/23 | | 10-K | | | | 1 | | Part Ii | 1 |
11/14/23 | | 10-Q | | | | 1 | | Part Ii -- Other Information | 3 |
4/17/23 | | 10-K | | | | 1 | | Part Iii | 1 |
| | | | | | 1 | | Part Iv | 1 |
5/16/23 | | 424B3 | | | | 1 | | Plan of Distribution | 2 |
5/9/23 | | S-1/A | | | | 1 | | Power of Attorney for Rennova Health, Inc. (included on the signature page of the Registration Statement)(2) | 1 |
4/17/23 | | 10-K | | | | 1 | | Principal Accountant Fees and Services | 1 |
5/16/23 | | 424B3 | | | | 1 | | Principal Stockholders | 2 |
4/17/23 | | 10-K | | | | 1 | | Properties | 1 |
5/16/23 | | 424B3 | | | | 1 | | Prospectus Summary | 2 |
11/14/23 | | 10-Q | | | | 1 | | Quantitative and Qualitative Disclosures About Market Risk | 4 |
4/17/23 | | 10-K | | | | 1 | | Report of Independent Registered Public Accounting Firm | 1 |
| | | | | | 1 | | Reserved | 1 |
11/14/23 | | 10-Q | | | | 1 | | Risk Factors | 6 |
4/17/23 | | 10-K | | | | 1 | | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | 1 |
5/16/23 | | 424B3 | | | | 1 | | Selling Stockholders | 2 |
| | | | | | 1 | | Shares Eligible for Future Sale | 2 |
11/14/23 | | 10-Q | | | | 1 | | Signatures | 4 |
| | | | | | 1 | | Unregistered Sales of Equity Securities and Use of Proceeds | 3 |
4/17/23 | | 10-K | | | | 1 | | Unresolved Staff Comments | 1 |
5/16/23 | | 424B3 | | | | 1 | | Use of Proceeds | 2 |
| | | | | | 1 | | Where You Can Find Additional Information | 2 |